Where to Invest in the Fight Against Cancer w/ Brad Loncar, Loncar Investments


One of the biggest biotech meetings of the year – ASCO – is about to get underway. This conference is huge, from both a medical and an investment perspective. To talk about it, Marc is joined by Brad Loncar, founder of the Loncar Cancer Immunotherapy ETF (Nasdaq: CNCR).

Marc also wishes a happy 120th birthday to the Dow Jones Industrial Average. And later, he discusses corporate layoffs and whether this information should inform your decision to buy or dump a stock.

View the transcript.